United States · Venture startup

Who invested in Spinogenix

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$13Mraised across 2 rounds since 2024, from 2 sources

$2.8MVenture$11MRound
Latest round
Round, $11MNov 2025
Step-upi
3.8×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025
$2.8MVenture$11MRound
First round
Venture, $2.8M
Jun 2024
Biggest round
$11M
Round · Nov 2025
Between rounds
18 months
from the last two

The rounds

  1. Nov 2025
    Round$11M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $11M sold, first sale Nov 2025

  2. Jun 2024
    Venture$2.8M1 new

    Source recordedSEC filing: $2.8M sold, first sale Jun 2024

Founders and team

From Spinogenix's own website: 1 on the team.

  • Ryan MacDonaldChief Business Officer

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Spinogenix

Who invested in Spinogenix?

Spinogenix's investors include National Institutes of Health.

How much has Spinogenix raised?

Spinogenix has raised $13M across 2 rounds since 2024.

When did Spinogenix last raise?

Spinogenix's most recent round, $11M, was in Nov 2025.

What was Spinogenix's biggest round?

Its most recent round, $11M in Nov 2025, is also its largest on record.

Who backed Spinogenix first?

Spinogenix's first round on record, in Jun 2024, was backed by National Institutes of Health.

What stage is Spinogenix at?

Spinogenix's latest named round is a Venture, in Jun 2024.

Where is Spinogenix based?

Spinogenix is based in the United States.

Companies like Spinogenix

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.